BCHE and Alzheimer disease: Currently approved drugs for the treatment of AD include cholinesterase inhibitors (donepezil, rivastigmine, and galantamine), an NMDA acid receptor antagonist (memantine), and a monoclonal antibody targeting Aβ(aducanumab), all of which are symptomatic.19